Panther Biotechnology Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

  • Investments
  • 2

Panther Biotechnology General Information

Description

Developer of small molecule therapeutics designed to treat neoplastic, autoimmune and antiviral disorders. The company's small molecule therapeutics combines transferrin glycoproteins with Doxorubicin for targeted delivery to tumors with reduced side effects, enabling leukemia, lymphoma and myeloma patients to begin treatment more quickly, resulting in a higher likelihood of a successful treatment.

Contact Information

Formerly Known As
NEF Enterprises
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 888 Prospect Street
  • Suite 200
  • La Jolla, CA 92037
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 888 Prospect Street
  • Suite 200
  • La Jolla, CA 92037
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Panther Biotechnology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Panther Biotechnology‘s full profile, request access.

Request a free trial

Panther Biotechnology Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Panther Biotechnology‘s full profile, request access.

Request a free trial

Panther Biotechnology Acquisitions (2)

Panther Biotechnology’s most recent deal was a Reverse Merger with ProBility Media. The deal was made on 08-Nov-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ProBility Media 08-Nov-2016 Reverse Merger Educational and Training Services (B2C)
Faulk Pharmaceuticals 16-Jul-2015 Merger/Acquisition Biotechnology
To view Panther Biotechnology’s complete acquisitions history, request access »

Panther Biotechnology FAQs

  • When was Panther Biotechnology founded?

    Panther Biotechnology was founded in 2011.

  • Where is Panther Biotechnology headquartered?

    Panther Biotechnology is headquartered in La Jolla, CA.

  • What industry is Panther Biotechnology in?

    Panther Biotechnology’s primary industry is Biotechnology.

  • Is Panther Biotechnology a private or public company?

    Panther Biotechnology is a Private company.

  • What is Panther Biotechnology’s current revenue?

    The current revenue for Panther Biotechnology is .

  • How much funding has Panther Biotechnology raised over time?

    Panther Biotechnology has raised $280K.

  • Who are Panther Biotechnology’s investors?

    Chicago Venture Partners has invested in Panther Biotechnology.

  • When was Panther Biotechnology acquired?

    Panther Biotechnology was acquired on 08-Nov-2016.

  • Who acquired Panther Biotechnology?

    Panther Biotechnology was acquired by ProBility Media.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »